BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• InMode to Participate in Upcoming Virtual Investor Conferences in November

  InMode Ltd. today announced that Moshe Mizrahy , Chief Executive Officer and Yair Malca , Chief Financial Officer will participate in the following upcoming virtual investor conferences:

  November 4, 2021

   · 

  1 min read
• Biotech Bay

  Omnilux Cohosts November 9th Webcast with MedEsthetics Magazine

  Today, GlobalMed Technologies (GMT), the manufacturer of Omnilux™ LED devices for professional and home use, announces an upcoming free educational webcast

  November 4, 2021

   · 

  2 min read
• Business

  Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones

  Akebia Therapeutics®, Inc. today reported financial results for the third quarter ended September 30, 2021 and highlighted recent corporate milestones.

  November 4, 2021

   · 

  15 min read
• Biotech Bay

  ArsenalBio Announces Participation in Upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting

  ArsenalBio today announced that it will present pre-clinical data from AB-X, the company’s integrated circuit T cell therapy program for the treatment of ovarian cancer (OC), at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting taking place November 10-14, 2021

  November 4, 2021

   · 

  2 min read
• FDA

  GenBody’s Anterior Nasal Swab COVID-19 Antigen Test Granted FDA Emergency Use Authorization as Part of an Effort to Meet Increased National Demand Amid Rapid Test Shortage

  Nov. 4, 2021 12:00 UTC GenBody’s direct anterior nasal swab COVID-19 antigen test becomes the company’s second test to receive FDA Emergency Use Authorization

  November 4, 2021

   · 

  4 min read
• Drug Development

  Ambrx Biopharma Inc. Announces First Patient Dosed in its Global Phase 2 ACE-Breast-03 Clinical Study of ARX788 for the Treatment of HER2-Positive Metastatic Breast Cancer

  Ambrx Biopharma Inc. today announced the first patient has been dosed in its global ACE-Breast-03 Phase 2 clinical study of ARX788 in patients with HER2-positive metastatic breast cancer.

  November 4, 2021

   · 

  4 min read
• Business

  Better Therapeutics Appoints Thiago Licias de Oliveira as Its Chief People Officer

  Better Therapeutics, Inc. today announced the appointment of Thiago Licias de Oliveira as its Chief People Officer.

  November 4, 2021

   · 

  5 min read
• Edesa Biotech Extends COVID-19 Clinical Study to Poland

  Edesa Biotech, Inc. today announced that Polish regulators have approved a clinical trial application for the investigational use of the company’s monoclonal antibody candidate, designated EB05

  November 4, 2021

   · 

  7 min read
• Biotech Beach

  Escient Pharmaceuticals Announces Data Presentations Highlighting the Preclinical and Clinical Development of EP547 at AASLD The Liver Meeting® Digital Experience 2021

  Escient Pharmaceuticals Announces Data Presentations Highlighting the Preclinical and Clinical Development of EP547 at AASLD The Liver Meeting ® Digital Experience 2021

  November 4, 2021

   · 

  4 min read
• Business

  Albireo Reports Q3 Financial Results and Business Update

  Albireo Pharma, Inc. today provided a business update and reported financial results for the third quarter ended September 30, 2021.

  November 4, 2021

   · 

  19 min read